The study is a prospective cervical cancer screening intervention in the nonclinical setting of a mobile testing unit in a vehicle, using point-of-care HPV PCR tests with self-collected vaginal swabs.
It is designed for women with limited access to healthcare and prevention in underprivileged municipalities in the greater Paris area (Seine-Saint-Denis department, detailed in Annexe 3).
HPV positive participants will receive counseiling and guidance to help them find a healthcare professional to take care of their needs
- Women from 30 to 65 years of age presenting to the " Bus Santé " nonclinical testing unit, eligible to cervical cancer screening by an HPV-HR test
Women affiliated to the French social security or immigrants benefiting from the state medical aid program for undocumented immigrants (Aide Médicale d'Etat). The inclusion of people not affiliated to a social security system is an exception and depends on the decision of the Personal Protection Committee, if it is based on an expected benefit for these people of a nature to justify the foreseeable risk incurred.
Women living in shelters and hostels, women living in the streets, in squats, hot-bedding arrangements, emergency social housing;
Recent immigrants, documented or undocumented;
Screened for cervical cancer by a PAP smear in the last 3 years or by an HPV test in the last 5 years,
Women on their period (haemoglobin inhibits PCRs)
Pregnancy in the 2nd and 3rd trimesters
Total hysterectomy; absence of a vagina
Single group
HPV self sampling
Other interventionSelected women will perform a vaginal self-sampling using a swab
Total number and proportion of eligible women (age 30 to 65, unscreened for cervical cancer for 3 to 5 years) who had an HPV PCR test on a self-collected vaginal sample when offered in a nonclinical setting by the Bus Santé de Seine-Saint-Denis
Declined to participate: number and why
Description of the barriers to cervical cancer screening in the target population
Proportion of complete HPV-HR PCRs run onboard the Bus and proportion with same-day results available to the participants
Frequency of positive HPV-HR tests and of invalid HPV-HR tests using SCVS samples
Click on the lead sponsor to view all of their trials.
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Lead sponsor
Hospital Avicenne
Collaborator
National Cancer Institute, France
Collaborator
INSERM UMR S 1136
Collaborator
Institut National de la Santé Et de la Recherche Médicale, France
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
